Hermab 150 MG Injection is used to treat HER2-positive breast cancer, where cancer cells produce excessive amounts of HER2 protein on their surface. It belongs to the monoclonal antibody class of medications that work as targeted therapy for specific cancer types.
In addition to breast cancer, this medicine is also used to manage metastatic gastric cancer (stomach cancer) that shows HER2 overexpression. In both cancer types, doctors must confirm the presence of HER2 overexpression through diagnostic testing before starting treatment.
This medicine must be administered intravenously by trained healthcare professionals in a clinical setting. Before beginning treatment, inform your doctor about any existing medical conditions, particularly heart disease, lung problems, or previous allergic reactions to similar medications. Report any side effects you experience during treatment to your doctor immediately. Continue with the treatment for the full duration prescribed by your doctor for the best results.